The delivery of ectopic miR-145-5p through the development of miRNA-145-based magnetic nanoparticle formulation downregulated oncogenic targets such as MUC1, OCT4, and EGFR, thereby efficiently inhibiting tumor growth and metastases in mice [45, 46]. The gene discussed is MUC1; the disease is neoplasm.